Filed: 2/12/2026ACC: 0001819257-26-000002
📋 What this filing means
PATIENT SQUARE CAPITAL LP filed this quarterly 13F‑HR report disclosing 28 equity positions with a total reported market value of $467.13M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
28
Positions
$467.13M
Total AUM (reported)
20.34M
Total Shares
Allocation by class
SHS$177.20M37.9%
COM$136.03M29.1%
COM PAR $.01$46.47M9.9%
SPONSORED ADS$45.47M9.7%
COM NEW$40.09M8.6%
SPONSORED ADR$21.86M4.7%
Portfolio Concentration
Top 3$247.26M52.9%
4–10$114.66M24.5%
11–25$97.70M20.9%
Rest$7.51M1.6%
Top 3 weight
52.9%
Top 10 weight
77.5%
Voting Authority Distribution
Total shares with voting rights: 20.34M
Sole
Full voting authority
20.34M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole28
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings28
Rows:
ROIVANT SCIENCES LTD
SOLEShares8.17M
TypeSH
Market value$177.20M
37.93%
Sole
8.17M
Shared
0.00
None
0.00
INSMED INC
SOLEShares267K
TypeSH
Market value$46.47M
9.95%
Sole
267K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares298.68K
TypeSH
Market value$23.59M
5.05%
Sole
298.68K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares26K
TypeSH
Market value$21.86M
4.68%
Sole
26K
Shared
0.00
None
0.00
BEONE MEDICINES LTD
SOLEShares69.31K
TypeSH
Market value$21.06M
4.51%
Sole
69.31K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares130K
TypeSH
Market value$17.53M
3.75%
Sole
130K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares542.70K
TypeSH
Market value$15.06M
3.22%
Sole
542.70K
Shared
0.00
None
0.00
EYEPOINT INC
SOLEShares780K
TypeSH
Market value$14.25M
3.05%
Sole
780K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares320K
TypeSH
Market value$12.93M
2.77%
Sole
320K
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares120K
TypeSH
Market value$11.97M
2.56%
Sole
120K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares317.37K
TypeSH
Market value$11.27M
2.41%
Sole
317.37K
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares139K
TypeSH
Market value$10.82M
2.32%
Sole
139K
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares227K
TypeSH
Market value$7.83M
1.68%
Sole
227K
Shared
0.00
None
0.00
DBV TECHNOLOGIES S A
SOLEShares359.05K
TypeSH
Market value$6.88M
1.47%
Sole
359.05K
Shared
0.00
None
0.00
ALLOGENE THERAPEUTICS INC
SOLEShares4.96M
TypeSH
Market value$6.80M
1.46%
Sole
4.96M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares150K
TypeSH
Market value$6.18M
1.32%
Sole
150K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares136.50K
TypeSH
Market value$6.12M
1.31%
Sole
136.50K
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares210K
TypeSH
Market value$6.10M
1.31%
Sole
210K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares490K
TypeSH
Market value$5.95M
1.27%
Sole
490K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares74K
TypeSH
Market value$5.88M
1.26%
Sole
74K
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares311.97K
TypeSH
Market value$5.67M
1.21%
Sole
311.97K
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares150K
TypeSH
Market value$4.91M
1.05%
Sole
150K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares308.14K
TypeSH
Market value$4.75M
1.02%
Sole
308.14K
Shared
0.00
None
0.00
ASSEMBLY BIOSCIENCES INC
SOLEShares127K
TypeSH
Market value$4.32M
0.92%
Sole
127K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares350K
TypeSH
Market value$4.23M
0.91%
Sole
350K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTDSOLE | SHS | 8.17M | SH | $177.20M 37.93% | 8.17M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 267K | SH | $46.47M 9.95% | 267K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 298.68K | SH | $23.59M 5.05% | 298.68K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 26K | SH | $21.86M 4.68% | 26K | 0.00 | 0.00 |
BEONE MEDICINES LTDSOLE | SPONSORED ADS | 69.31K | SH | $21.06M 4.51% | 69.31K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 130K | SH | $17.53M 3.75% | 130K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 542.70K | SH | $15.06M 3.22% | 542.70K | 0.00 | 0.00 |
EYEPOINT INCSOLE | COM NEW | 780K | SH | $14.25M 3.05% | 780K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 320K | SH | $12.93M 2.77% | 320K | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 120K | SH | $11.97M 2.56% | 120K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 317.37K | SH | $11.27M 2.41% | 317.37K | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | COM | 139K | SH | $10.82M 2.32% | 139K | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 227K | SH | $7.83M 1.68% | 227K | 0.00 | 0.00 |
DBV TECHNOLOGIES S ASOLE | SPONSORED ADS | 359.05K | SH | $6.88M 1.47% | 359.05K | 0.00 | 0.00 |
ALLOGENE THERAPEUTICS INCSOLE | COM | 4.96M | SH | $6.80M 1.46% | 4.96M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 150K | SH | $6.18M 1.32% | 150K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 136.50K | SH | $6.12M 1.31% | 136.50K | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCSOLE | COM | 210K | SH | $6.10M 1.31% | 210K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 490K | SH | $5.95M 1.27% | 490K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 74K | SH | $5.88M 1.26% | 74K | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 311.97K | SH | $5.67M 1.21% | 311.97K | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 150K | SH | $4.91M 1.05% | 150K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 308.14K | SH | $4.75M 1.02% | 308.14K | 0.00 | 0.00 |
ASSEMBLY BIOSCIENCES INCSOLE | COM NEW | 127K | SH | $4.32M 0.92% | 127K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 350K | SH | $4.23M 0.91% | 350K | 0.00 | 0.00 |
Page 1 of 2